Range Low Price High Price Comment
30 days $0.0200 $0.120 Thursday, 28th Mar 2024 CALA stock ended at $0.0246. This is 22.75% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 0% from a day low at $0.0246 to a day high of $0.0246.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2023-08-22 $0.0500 $0.0500 $0.0500 $0.0500 273
2023-08-21 $0.0500 $0.0500 $0.0500 $0.0500 1 373
2023-08-18 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-08-17 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-08-16 $0.0500 $0.0500 $0.0500 $0.0500 585
2023-08-15 $0.0500 $0.0500 $0.0500 $0.0500 820
2023-08-14 $0.0500 $0.0500 $0.0500 $0.0500 303
2023-08-11 $0.0510 $0.0510 $0.0510 $0.0510 382
2023-08-10 $0.0700 $0.125 $0.0510 $0.0510 1 310
2023-08-09 $0.0500 $0.0510 $0.0500 $0.0510 2 134
2023-08-08 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-08-07 $0.0500 $0.0500 $0.0500 $0.0500 270
2023-08-04 $0.0500 $0.0500 $0.0500 $0.0500 500
2023-08-03 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-08-02 $0.0500 $0.0500 $0.0500 $0.0500 1 247
2023-08-01 $0.0500 $0.0500 $0.0500 $0.0500 1 634
2023-07-31 $0.0500 $0.0500 $0.0500 $0.0500 2 039
2023-07-28 $0.0500 $0.0500 $0.0500 $0.0500 189
2023-07-27 $0.0300 $0.0820 $0.0300 $0.0820 102 373
2023-07-26 $0.0210 $0.0400 $0.0200 $0.0400 151 038
2023-07-25 $0.0500 $0.0500 $0.0150 $0.0150 315 947
2023-07-24 $0.0500 $0.0500 $0.0500 $0.0500 213
2023-07-21 $0.0500 $0.0500 $0.0500 $0.0500 0
2023-07-20 $0.0500 $0.0500 $0.0500 $0.0500 3 674
2023-07-19 $0.0700 $0.0700 $0.0500 $0.0500 26 268
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT